According to Maxmen (2018), she states that “Despite the setbacks and the long delays, many argue that science is operating as it should- being self-critical and open to revision. In five years’ time, researchers should be able to pinpoint specific aberrations in the immune, metabolic, endocrine or nervous systems of people with ME/CFS, and perhaps find genetic predispositions to the condition. These indicators might yield diagnostic tests- and further down the road, treatments”.
Amy Maxmen 2018, ‘A reboot for chronic fatigue syndrome research’, Nature International Journal of Science, vol. 533, pp. 14-17, doi:10.1038/d41586-017-08965-0
Click here to view the whole article